ArticlePloS one2025
Osteoporosis is associated with increased CVD mortality and all-cause mortality in alcohol-consuming individuals: A cohort study using data from NHANES.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Monocyte-to-Albumin Ratio (MAR) Is Associated With All-Cause Mortality in Adult Stroke Patients: Evidence From NHANES (1999-2018).Stroke research and treatment · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOsteoporosis, a skeletal disorder characterized by reduced bone density and increased fracture risk, imposes a significant global health burden, particularly in aging populations. Previous studies have highlighted the negative impact of alcohol consumption on bone health, but the interplay between osteoporosis and mortality risk in alcohol-consuming individuals remains underexplored. This study aimed to investigate the association between osteoporosis and cardiovascular disease (CVD) mortality and all-cause mortality in U.S. adults who consume alcohol.
methodsThis prospective cohort study utilized data from the National Health and Nutrition Examination Survey (NHANES) spanning five cycles (2005-2010, 2013-2014, and 2017-2018). A total of 12,178 alcohol-consuming participants aged 20 years and older were included after excluding those with missing data or non-drinking status. Bone density was measured using dual-energy X-ray absorptiometry (DXA), and osteoporosis was defined using World Health Organization (WHO) T-score criteria (T-score ≤ -2.5). Mortality data were obtained through linkage with the National Death Index (NDI). Multivariable Cox proportional hazards regression models were employed to assess the relationship between osteoporosis and mortality outcomes, adjusting for demographic, socioeconomic, and clinical covariates.
resultsKaplan-Meier survival analysis revealed higher all-cause and CVD mortality rates in participants with osteoporosis compared to those without (Log-rank test P < 0.001 for both). After adjusting for potential confounders, osteoporosis was associated with a 1.60-fold increased risk of all-cause mortality (HR = 1.60, 95% CI = 1.26-2.03, P < 0.001) and a 1.55-fold increased risk of CVD mortality (HR = 1.55, 95% CI = 1.06-2.28, P = 0.025). Stratified analyses across age, sex, smoking status, and cardiovascular risk factors showed consistent results, with no significant interaction effects (P > 0.05). Sensitivity analyses confirmed the robustness of these findings.
conclusionOsteoporosis is positively associated with increased risks of all-cause and CVD mortality in alcohol-consuming individuals. These findings underscore the need for further research to elucidate the underlying mechanisms and inform preventive strategies targeting this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.